Literature DB >> 22984024

Mycobacterium avium complex lung disease therapy.

David E Griffith, Kevin L Winthrop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22984024     DOI： 10.1164/rccm.201207-1321ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.

Authors:  N El-Zeenni; S Chanoine; C Recule; J-P Stahl; M Maurin; B Camara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-24       Impact factor: 3.267

2.  Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.

Authors:  Jennifer Adjemian; D Rebecca Prevots; Jack Gallagher; Kylee Heap; Renu Gupta; David Griffith
Journal:  Ann Am Thorac Soc       Date:  2014-01

3.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

4.  Draft Genome Sequence of Mycobacterium avium 11.

Authors:  Michelle Yee; David Klinzing; Jun-Rong Wei; Martin Gengenbacher; Eric J Rubin; Jung-Yien Chien; Po-Ren Hsueh; Thomas Dick
Journal:  Genome Announc       Date:  2017-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.